SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-005031
Filing Date
2024-01-19
Accepted
2024-01-19 08:44:25
Documents
18
Period of Report
2024-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243583d4_8k.htm   iXBRL 8-K 33891
2 EXHIBIT 1.1 tm243583d4_ex1-1.htm EX-1.1 254189
3 EXHIBIT 5.1 tm243583d4_ex5-1.htm EX-5.1 11712
4 EXHIBIT 99.1 tm243583d4_ex99-1.htm EX-99.1 9614
8 GRAPHIC tm243583d4_ex99-1img01.jpg GRAPHIC 4186
9 GRAPHIC tm243583d4_ex5-1img01.jpg GRAPHIC 3212
10 GRAPHIC tm243583d4_ex5-1img03.jpg GRAPHIC 1856
  Complete submission text file 0001104659-24-005031.txt   567061

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20240119.xsd EX-101.SCH 3021
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20240119_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20240119_pre.xml EX-101.PRE 22363
12 EXTRACTED XBRL INSTANCE DOCUMENT tm243583d4_8k_htm.xml XML 3311
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 24543818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)